Each mL contains:
Fluorometholone USP                                                   1 mg
Neomycin Sulphate IP equivalent to Neomycin        3.5 mg
Benzalkonium Chloride IP/USNF                                 0.04 mg
Purified Water IP                                                              q.s.

INDICATIONS AND USAGE:

1. FML NEO is effective in the treatment of infectious conjunctivitis due to organisms sensitive to Neomycin.
2. FML NEO may be used for the treatment of the anterior segment inflammatory disorders which may be threatened with or complicated by bacteria sensitive to Neomycin.
3. FML NEO is effective following removal of foreign bodies as well as before and after surgery where the possibility of infection with susceptible organisms exists.

DOSAGE AND ADMINISTRATION:
1-2 drops in the conjunctival sac two to four times daily. During the initial 24 to 48 hours the dosage may be safely increased to 1 drop every hour. Care should be taken not to discontinue therapy prematurely.

HOW SUPPLIED:
FML NEO is available as a sterile ophthalmic suspension in 5 mL plastic dropper bottle.

Prescribing Information